Business · 09/10/2026

Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof

The National Institute of Allergy and Infectious Diseases is contemplating the grant of an exclusive, sublicensable patent license for an antibody specifically binding to Severe Fever With Thrombocytopenia Syndrome Virus antigen and its use.